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Abstract
We present the solid phase synthesis of carbohydrate-functionalized oligo(amidoamines) with different functionalization patterns
utilizing a novel alphabet of six differently glycosylated building blocks. Highly efficient in flow conjugation of thioglycosides to a
double-bond presenting diethylentriamine precursor is the key step to prepare these building blocks suitable for fully automated
solid-phase synthesis. Introduction of the sugar ligands via functionalized building blocks rather than postfunctionalization of the
oligomeric backbone allows for the straightforward synthesis of multivalent glycoligands with full control over monomer sequence
and functionalization pattern. We demonstrate the potential of this building-block approach by synthesizing oligomers with
different numbers and spacing of carbohydrates and also show the feasibility of heteromultivalent glycosylation patterns by
combining building blocks presenting different mono- and disaccharides.
Introduction
Multivalent carbohydrate ligand–protein receptor interactions
play a key role for many events in glycobiology such as
cell–cell or pathogen recognition [1]. Therefore, carbohydrate
functionalization of non-natural materials such as polymers or
dendrimers allows for bioactive materials that are used to
modulate cellular behavior [1-3]. Since single carbohydrate
ligand–protein interactions are usually weak [4], several sugar
ligands have to be introduced in order to achieve the desired
biological effect [4]. This multivalent presentation of ligands
then results in an increased binding affinity to the targeted
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protein receptors [4]. It is well understood that the number and
spacing of ligands have a tremendous influence on the resulting
binding and thus biological properties [5-7]. Therefore, in order
to understand and explore these interactions and their potential
for biomedical applications, a more detailed look at the binding
mechanisms as well as structure–activity relationship studies of
multivalent glycomaterials is required.
Multivalent sugar presentation has been realized on a variety of
different scaffolds such as polymers [8,9], dendrimers [10] or
naturally-occurring scaffolds such as peptides [11-13] or
oligonucleotides [14]. Such constructs have contributed to our
current understanding of multivalent interactions [5]. Neverthe-
less, binding studies on multivalent compounds with different
scaffold architectures or combinations of different sugar ligands
are limited due to the often undefined chemical composition,
limited variations in architecture and functionalization as well
as unspecific biological activity of the scaffolds. Precision
oligo/polymers are a novel class of defined artificial scaffolds
having the potential to bridge this current gap of artificial
carbohydrate presenting scaffolds and to be an important plat-
form for structure–activity relationship studies [15-17]. Preci-
sion macromolecules combine the advantages of synthetic scaf-
folds such as polymers with the advantages of naturally-occur-
ring scaffolds such as peptides as they are highly defined, versa-
tile in their structure (linear or branched) [18] and biocompat-
ible with a decreased risk of inherent immunogenicity [19].
Recently, we showed that monodisperse, sequence-defined
glycooligomers obtained by sequential addition of building
blocks on solid support are valuable tools for tuning and under-
standing carbohydrate–lectin interactions [20]. Carbohydrate
conjugation was achieved by copper-catalyzed azide alkyne
cycloaddtion (CuAAC) of carbohydrate ligands on alkyne
presenting oligomers [21]. As an alternative conjugation ap-
proach to CuAAc, a very efficient thiol–ene coupling (TEC)
[22-25] protocol in a continuous flow photoreactor was devel-
oped involving post functionalization of alkene presenting
oligomers by thioglycosides [26]. The flow system allows for
precise control over the reaction conditions, is easy to scale up
and provides efficient irradiation of the samples by virtue of a
sub-millimeter path length. Continuous removal of the desired
product minimizes unwanted secondary reaction pathways [27-
39]. We also introduced the so-called building block approach
in the context of thiol–ene coupling via the continuous-flow
technique. A first example involved conjugating a glucose
ligand to a building block and subsequent solid phase assembly
of a glycooligomer [26].
When compared to postfunctionalization, the building-block ap-
proach allows not only control of the ligand positioning, but
also enables well-defined sequences with different types of
ligands: Simply by choosing from an alphabet of building
blocks, applying them for solid-phase synthesis and final
cleavage from the resin, the desired multivalent structures can
be obtained. Heteromultivalent glycooligomers presenting
different sugars at different positions along the scaffold should
be accessible by combining different carbohydrate functional-
ized building blocks and without the requirement of complex
protecting group or sequential functionalization strategies [40].
In order to explore the feasibility of the building-block ap-
proach for the synthesis of precision glycooligo/polymers, in
this work we report on the reaction of several thioglycosides
and the double bond presenting diethylenetriamine succinic acid
building block (DDS) 1, giving access to a small alphabet of
carbohydrate-functionalized building blocks. TEC in flow
enabled determining the reactivity of each thioglycoside at
>275 nm, leading to optimized reaction conditions for the
production of six glycosylated building blocks (Figure 1). These
building blocks can then be used for the assembly of monodis-
perse, sequence-defined glycooligomers via fully automated
standard amide coupling. Straightforward variations in the scaf-
fold architecture, number and distance of sugar ligands as well
as the sequence-defined introduction of different sugars are
demonstrated by choosing different building block combina-
tions during solid-phase synthesis.
Results and Discussion
For the preparation of the desired sugar building blocks double-
bond presenting building block DDS 1 and thioglycosides 2–7
are required. The large scale synthesis of DDS 1 was achieved
according to a published procedure [26]. The required β-thio-
glycosides 2–7 were prepared via their corresponding glycosyl
bromides followed by SN2 displacement of the anomeric bro-
mide with thiourea [41] or Na2S/CS2 [42].
DDS 1 and thioglycosides 2–7 were subjected to TEC in flow at
>275 nm (Scheme 1). A FEP flow photoreactor equipped with a
Pyrex-filtered medium pressure Hg lamp (400 Watt, λmax =
366 nm) cooled to room temperature was employed [43].
Continuous reagent delivery was ensured by a standard com-
mercially available syringe pump (for details see Supporting
Information File 1). Reactivity evaluation studies were per-
formed utilizing a 2 mL FEP loop, for the gram-scale produc-
tion of glycosylated building blocks a 5 mL FEP loop was used.
This particular photochemical set up (Figure 2a) allows for
several reaction parameters to be studied for later high scale
synthesis of the glycosylated building blocks 8–13 while using
only small amounts of reagents for optimization. As thiol–ene
addition is strongly concentration dependent [26], similar
concentrations for thioglycosides 2–7 during TEC are required
for a valid comparison. Due to reagent solubility, a concentra-
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Figure 1: Versatile synthetic strategy for access to multivalent glycoligands: First, the building block DDS 1 is functionalized with different acetyl-
protected thioglycosides 2–7 via thiol–ene addition in flow at >275 nm, resulting in a building block alphabet of six different glyco-building blocks 8–13.
These building blocks are then applied for the solid-phase synthesis of sequence-defined glycooligomers 14–16.
Scheme 1: Carbohydrate functionalization of DDS.
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Table 1: Overview of the preparation of glycosylated building block and used upscale conditions.
Building block Thiol component Equiv Residence time Conversion Yield
β-GlcS_DDS 8 β-Glc(OAc)4-SH 2 1.5 30 min 95% 84%
β-GalS_DDS 9 β-Gal(OAc)4-SH 3 1.5 30 min 94% 81%
β-RhaS_DDS 10 β-Rha(OAc)3-SH 4 1.5 30 min 95% 89%
β-GlcNAcS_DDS 11 β-GlcNAc(OAc)3-SH 5 2 30 min >95% 81%
β-GalNAcS_DDS 12 β-GalNAc(OAc)3-SH 6 2 30 min >95% 85%
β-LacS_DDS 13 β-Lac(OAc)7-SH 7 1.5 30 min 84% 70%
tion of 0.1 M could be only realized by premixing all reagents
before injection. In this case it is important to notice that no
background reactivity could be measured when performing the
reaction without irradiation under similar flow conditions.
Figure 2: a) Schematic diagram of the TEC photoflow reactor. b) Plot
of residence time versus conversion for the addition of the
β-Glc(OAc)4-SH 2, β-Gal(OAc)4-SH 3 and β-Lac(OAc)7-SH 7 to the
DDS building block 1.
Integration of the HPLC UV-signals at 254 nm was used to
establish residence time versus conversion plots (Figure 2). The
plots showed close to complete conversion within 30 min resi-
dence time and 1.5 equiv of thioglycoside β-Glc(OAc)4-SH 2
(95%) or β-Gal(OAc)4-SH 3 (94%) (Figure 2; Glc and Gal).
Similar reactivities were also observed for monosaccharides
4–6, supporting the substrate scope of this approach and its suit-
ability to access a library of differently glycosylated building
blocks. Referring to larger thio-substrate β-Lac(OAc)7-SH 7 a
diminished reactivity with the same previously mentioned reac-
tion conditions was determined (Figure 2b; Lac).
With optimized reaction conditions in place, large amounts of
glycosylated building blocks are required to support solid phase
oligomer synthesis. Large scale production of glycosylated
building blocks 8, 9, 10 and 13 relied on the previously estab-
lished conditions (30 min; 1.5 equiv thioglycoside; 0.1 M).
Although the reactivity of aminoglycosides 5 and 6 is in the
same range as that of glycosides 2–4, we chose a higher excess
of thiol component (2 equiv) for the production of glycosylated
building blocks 11 and 12, resulting in >95% conversion and an
easy purification of the reaction mixture. Using this process,
gram quantities of glycosylated building blocks 8–13 were
obtained in 70–89% isolated yield after purification (Table 1).
With the isolated and characterized glyco-building blocks 8–13
obtained via TEC in flow, we then assembled three different
glycooligomers 14–16 (Figure 3) to show the potential of the
building block approach for the straightforward synthesis of a
variety of differently glycosylated structures. The oligomer syn-
thesis is based on standard peptide synthesis protocols and
amide formation via activation of the building blocks’ free
carboxy group, coupling to the solid support followed by depro-
tection of the amino group (Figure 3). This allows us to synthe-
size chemically defined oligomers with full control over the
monomer sequence [15,16,18,26] using differently functional-
ized and spacer building blocks. Due to the use of fully func-
tionalized building blocks the desired product can be obtained
directly after cleavage from the resin and after overall deprotec-
tion.
In order to be suitable for solid-phase synthesis, the building
blocks have to be soluble in DMF or NMP, permanent protec-
tive groups have to be stable towards piperidine exposure and
the activated species should selectively react with primary
amines without prior decomposition. Indeed, all glyco-building
blocks described here, fulfil these criteria and can be applied for
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Figure 3: Solid phase coupling procedure and the obtained homo- and heteromultivalent glycoligands 14–16.
sequential coupling under PyBop or HATU activation and
Fmoc deprotection with 25% piperidine in DMF on solid
support (Figure 3). Final deprotection from the resin was
performed with TFA/DCM mixtures, followed by acetyl depro-
tection in solution under Zemplén conditions [44]. Although the
glycosylated building blocks 9–13 suffer from steric hindrance
and have a relatively high molecular weight in comparison to
amino acids, they show remarkably good coupling efficiency
during amide bond formation on solid support. Glycooligomer
14, combining three ß-GalS_DDS and three amino-diethoxy-
acetic acid (AEEAc) building blocks in alternating sequence,
was accessible in high yields (81%) and purity (94% deter-
mined via integration of the HPLC signal at 214 nm) by refer-
ring only to single coupling (5 equiv) for one hour using PyBop
activation (see Supporting Information File 1). After diethyl
ether precipitation no further purification of compound 14 was
necessary. This structure represents an example for a combina-
tion of glycosylated and non-glycosylated building blocks that
allows for the variation of the density, number and spacing of
sugar ligands along the scaffold. In order to test whether the
Beilstein J. Org. Chem. 2013, 9, 2395–2403.
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building block approach is also suitable for the direct introduc-
tion of larger sugar ligands such as the Lac disaccharide, we
synthesized structure 15 presenting three Lac ligands placed
right next to each other in a short oligomer chain. Indeed,
depending on the building blocks applied and oligomer struc-
tures targeted, different activating reagents are required.
Glycooligomer 15 introducing Lac groups was obtained as
highly pure material after solid-phase synthesis using HATU
activation instead of PyBop followed by HPLC purification.
Another important advantage of the presented building block
approach is the straightforward access to so-called heteromulti-
valent glycooligomers. Here different sugar ligands are
presented at different positions along the oligomer chain. To
date, such heteromultivalent systems are mainly obtained by
functionalization with mixtures of sugar ligands that do not
allow for a precise positioning of the different sugar ligands
[9,45]. Alternatively, a polymer-analogue strategy is required
where different functional groups are placed along a polymer
chain that allow for orthogonal conjugation strategies intro-
ducing the different sugars sequentially [37,46]. Our approach
simply relies on choosing from our differently glycosylated
building blocks that are introduced in the desired pattern by
automated solid-phase synthesis. As a proof of principle we
synthesized glycoligand 16 as a multivalent scaffold that
presents two different monosaccharides. β-GlcNAc and β-Gal
are exposed in alternating fashion with an overall oligomer
length of six building blocks and a molecular weight of
3000 Da. Similar to glycooligomer 15 this structure was
obtained as highly pure material after solid-phase synthesis
using HATU activation and HPLC purification.
Conclusion
In this article we reported on the synthesis of glycosylated
building blocks via photochemical thiol–ene chemistry in a
continuous-flow reactor using five different monosaccharides
and one disaccharide. We showed that this flow set up provides
excellent conversion rates with several substrates. All monosac-
charides were shown to react under the same conditions with
equivalent conversion rates, whereas the peracetylated β-thio-
lactose as a disaccharide showed slightly diminished reactivity.
Additionally, these small scale reactions were transferred into
the gram-scale production of six different glycosylated building
blocks.
These carbohydrate presenting building blocks were then
applied for solid-phase synthesis resulting in three monodis-
perse, sequence-defined glycooligomers with different glycosyl-
ation patterns. The building-block approach for the synthesis of
glycooligomers thus allows for the control of the ligand posi-
tioning as well as the straightforward introduction of defined
sequences of different types of ligands. Ongoing studies focus
on the synthesis of a larger set of different glycooligo/polymers
and the evaluation of their binding properties as sugar mimetics.
For example, homomultivalent oligomer 14 and analogues are
characterized for their interactions with asialoglycoprotein
receptors, while heteromultivalent oligomer 16 represents a
potential mimic of poly(lacNAc), which is known to be an
important naturally-occurring galectin binder.
Experimental
General TEC procedure. A photoreactor was set up using
5 mL (for optimization reactions 2 mL) loop of FEP tubing
around a Pyrex and a medium pressure Hg lamp [26,43]. A
recirculating chiller (Huber Unistat 360, filled with spectroscop-
ically pure water as coolant) was used to maintain the reactor at
a temperature of 25–30 °C (for further details see Supporting
Information File 1). Using a syringe pump (Harvard PHD2000),
a solution of DDS 1 (1.0 equiv), acetyl-protected thioglyco-
sidesglycoside 2–7 (1.5–2.0 equiv) and acetic acid (3 equiv) in
degassed methanol was injected into the photoreactor. The
entire reactor output was collected and evaporated under
reduced pressure to afford the crude material.
β-GlcS_DDS (8): A solution of acetyl protected β-thioglucose 2
(1.35 g; 3.69 mmol, 1.5 equiv) and DDS 1 (1.25 g; 2.46 mmol,
1.0 equiv) in MeOH (24 mL) and AcOH (0.42 mL) (residence
time, 30 min; flow rate 167 μL min−1) was reacted under photo-
chemical conditions according to the general TEC procedure.
The reactor outcome was concentrated and purified via silica
chromatography (DCM/MeOH + 1% AcOH 15:1) giving com-
pound 8 (1.8 g; 84%). The analytical data is in accordance with
published data [26].
β-GalS_DDS (9): A solution of acetyl protected β-thiogalac-
tose 3 (1.35 g; 3.69 mmol, 1.5 equiv) and DDS 1 (1.25 g;
2.46 mmol, 1.0 equiv) in MeOH (24 mL) and AcOH (0.42 mL)
(residence time, 30 min; flow rate 167 μL min−1) was reacted
under photochemical conditions according to the general TEC
procedure. The reactor outcome was concentrated and purified
via silica chromatography (DCM/MeOH + 1% AcOH 15:1)
giving compound 9 (1.74 g; 81%). IR (film) ν: 2945, 1748,
1225 cm−1; [α]D20 −32.19 (c 1, MeOH); 1H NMR (400 MHz,
CDCl3) 7.76 (d, J = 7.5, 2H), 7.58 (d, J = 7.4, 2H), 7.39 (t, J =
7.4, 2H), 7.30 (t, J = 7.4, 2H), 7.07–6.83 (m, 1H), 5.86–5.64 (m,
1H), 5.47–5.35 (m, 1H), 5.19 (t, J = 9.8, 1H), 5.10–4.97 (m,
1H), 4.65–4.27 (m, 3H), 4.25–3.80 (m, 4H), 3.62–3.18 (m, 8H),
2.73–2.53 (m, 4H), 2.52–2.29 (m, 4H), 2.12 (s, 3H), 2.05–1.99
(m, 6H), 1.97 (s, 3H), 1.76–1.50 (m, 4H); 13C NMR (100 MHz,
CDCl3) (mixture of rotamers) 175.0, 173.1, 172.9, 170.7, 170.4,
170.2, 169.9, 156.9, 143.9, 143.9, 141.4, 141.4, 127.9, 127.2,
125.2, 125.1, 120.2, 120.2, 84.1, 74.5, 72.0, 67.5, 67.5, 67.0,
61.5, 48.5, 48.3, 47.3, 45.9, 40.1, 39.9, 39.3, 38.6, 32.6, 32.4,
Beilstein J. Org. Chem. 2013, 9, 2395–2403.
2401
30.9, 29.8, 29.4, 29.4, 29.3, 24.5, 24.5, 20.9, 20.8, 20.8, 20.7;
HRMS (ESI) m/z: [M + Na]+ calcd for C42H53N3O15SNa,
894.3095; found, 894.3096; RP-HPLC analysis, 5% to 95%
MeCN in 10 min, retention time = 8.1 min.
β-RhaS_DDS (10): A solution of acetyl protected L-β-
thiorhamnose 4 (1.13 g; 3.69 mmol, 1.5 equiv) and DDS 1
(1.25 g; 2.46 mmol, 1.0 equiv) in MeOH (24 mL) and AcOH
(0.42 mL) (residence time, 30 min; flow rate 167 μL min−1)
was reacted under photochemical conditions according to the
general TEC procedure. The reactor outcome was concentrated
and purified via silica chromatography (DCM/MeOH + 1%
AcOH 17:1) giving compound 10 (1.78 g; 89%). IR (film) ν:
2940, 1745, 1630, 1224 cm−1; [α]D20 −5.83 (c 1, MeOH); 1H
NMR (400 MHz, CDCl3) 7.74 (d, J = 7.5, 2H), 7.57 (d, J = 7.4,
2H), 7.38 (t, J = 7.3, 2H), 7.29 (t, J = 7.6, 2H), 6.96 (br s, 1H),
5.86–5.65 (m, 1H), 5.30 (dd, J = 3.3, 1.5, 1H), 5.22–5.16 (m,
1H), 5.14 (s, 1H), 5.07 (t, J = 9.8, 1H), 4.46–4.26 (m, 2H),
4.24–4.12 (m, 2H), 3.67–3.09 (m, 8H), 2.82–2.23 (m, 8H),
2.17–2.09 (m, 3H), 2.04 (s, 3H), 1.97 (s, 3H), 1.73–1.56 (m,
4H), 1.19 (d, J 6.2, 3H); 13C NMR (100 MHz, CDCl3) (mix-
ture of rotamers) 175.3, 175.2, 174.9, 174.8, 173.1, 172.9,
170.4, 170.1, 170.1, 157.3, 156.9, 143.9, 143.9, 141.4, 141.4,
127.9, 127.2, 125.2, 125.1, 120.1, 120.1, 82.3, 71.8, 71.3, 69.7,
67.3, 67.0, 48.5, 48.2, 47.3, 46.2, 45.9, 40.1, 39.8, 39.2, 38.6,
32.6, 32.4, 31.1, 30.8, 30.8, 29.7, 29.4, 29.2, 29.1, 24.5, 24.4,
21.1, 20.9, 20.8, 17.5, 17.5;; HRMS (ESI) m/z: [M + Na]+ calcd
for C40H51N3O13SNa, 836.3040; found, 836.3056; RP-HPLC
analysis, 5% to 95% MeCN in 10 min, retention time = 7.8 min.
β-GlcNAcS_DDS (11): A solution of acetyl protected
β-thioglucosamine 5 (0.72 g; 1.97 mmol, 2.0 equiv) and DDS 1
(0.5 g; 0.99 mmol, 1.0 equiv) in MeOH (10 mL) and AcOH
(0.17 mL) (residence time, 30 min; flow rate 167 μL min−1)
was reacted under photochemical conditions according to the
general TEC procedure. The reactor outcome was concentrated
and purified via silica chromatography (DCM/MeOH + 1%
AcOH 10:1) giving compound 11 (0.70 g; 81%). IR (film) ν:
2940, 1744, 1654, 1229 cm−1; [α]D20 +25.65 (c 2, MeOH); 1H
NMR (400 MHz, CDCl3) 7.77–7.71 (m, 2H), 7.57 (d, J = 7.3,
2H), 7.37 (t, J = 7.4, 2H), 7.33–7.25 (m, 2H), 5.21–4.99 (m,
2H), 4.64–4.50 (m, 1H), 4.41–3.99 (m, 6H), 3.72–3.56 (m, 1H),
3.51–3.17 (m, 8H), 2.76–2.52 (m, 4H), 2.50–2.28 (m, 4H), 2.02
(s, 3H), 2.00–1.95 (m, 6H), 1.89 (d, J = 9.1 Hz, 2H), 1.75–1.42
(m, 2H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers)
174.8, 174.7, 173.2, 171.2, 171.2, 171.1, 170.1, 169.5, 169.5,
157.2, 157.0, 143.8, 141.3, 127.9, 127.2, 125.1, 120.1, 83.7,
83.7, 75.7, 74.1, 68.6, 68.6, 67.0, 66.9, 62.4, 53.0, 53.0, 48.2,
47.9, 47.2, 46.1, 45.8, 39.7, 38.5, 38.3, 32.3, 32.1, 30.9, 29.8,
29.3, 29.3, 28.3, 23.9, 23.8, 23.1, 20.9, 20.8, 20.7; HRMS (ESI)
m/z: [M + Na]+ calcd for C42H54N4O14SNa, 893.3255; found,
893.3263; RP-HPLC analysis, 5% to 95% MeCN in 10 min,
retention time = 7.1 min.
β-GalNAcS_DDS (12): A solution of acetyl protected β-thio-
galactosamine 6 (0.72 g; 1.97 mmol, 2.0 equiv) and DDS 1
(0.5 g; 0.99 mmol, 1.0 equiv) in MeOH (10 mL) and AcOH
(0.17 mL) (residence time, 30 min; flow rate 167 μL min−1)
was reacted under photochemical conditions according to the
general TEC procedure. The reactor outcome was concentrated
and purified via silica chromatography (DCM/MeOH + 1%
AcOH 10:1) giving compound 12 (0.73 g; 85%). IR (film) ν:
1746, 1655, 1236 cm−1; [α]D20 +145.42 (c 2, MeOH); 1H NMR
(400 MHz, CDCl3) 7.77–7.69 (m, 2H), 7.56 (d, J = 7.3, 2H),
7.36 (t, J = 7.4, 2H), 7.32–7.23 (m, 2H), 5.39–5.25 (m, 1H),
5.14–5.01 (m, 1H), 4.57 (t, J = 10.5, 1H), 4.41–3.94 (m, 6H),
3.90–3.77 (m, 1H), 3.54–3.04 (m, 8H), 2.78–2.52 (m, 4H),
2.51–2.27 (m, 4H), 2.10 (s, 3H), 2.05–1.84 (m, 9H), 1.79–1.45
(m, 4H); 13C NMR (100 MHz, CDCl3) (mixture of rotamers)
175.2, 174.8, 174.7, 173.1, 173.0, 171.5, 171.3, 170.8, 170.7,
170.5, 170.5, 157.2, 143.8, 143.8, 141.3, 128.0, 127.2, 125.2,
125.1, 120.1, 84.2, 84.0, 74.3, 71.7, 71.6, 67.0, 66.9, 61.8, 61.8,
49.2, 48.2, 47.8, 47.3, 46.2, 45.8, 39.7, 38.5, 38.4, 32.3, 32.1,
30.7, 30.6, 29.7, 29.6, 29.4, 28.4, 28.3, 23.9, 23.8, 23.2, 23.2,
20.8, 20.7; HRMS (ESI) m /z :  [M + Na]+  calcd for
C42H54N4O14SNa, 893.3255; found, 893.3247; RP-HPLC
analysis, 5% to 95% MeCN in 10 min, retention time = 7.1 min.
β-LacS_DDS (13): A solution of acetyl protected β-thiolactose
7 (0.79 g; 1.18 mmol, 1.5 equiv) and DDS 1 (0.4 g; 0.79 mmol,
1.0 equiv) in MeOH (7.9 mL) and AcOH (0.17 mL) (residence
time, 30 min; flow rate 167 μL min−1) was reacted under photo-
chemical conditions according to the general TEC procedure.
The reactor outcome was concentrated and purified via silica
chromatography (DCM/MeOH + 1% AcOH 15:1) giving com-
pound 13 (0.65 g; 70%). IR (film) ν: 1750, 1230, 1051 cm−1;
[α]D20 −35.00 (c 2, MeOH); 1H NMR (400 MHz, CDCl3) 7.72
(d, J = 7.5, 2H), 7.55 (d, J = 7.5, 2H), 7.37 (t, J = 7.3, 2H),
7.29–7.25 (m, 2H), 5.31 (s, 1H), 5.16 (dt, J = 9.2, 3.1, 1H), 5.06
(t, J = 7.9, 1H), 4.96–4.85 (m, 2H), 4.47–4.04 (m, 9H),
3.87–3.71 (m, 2H), 3.55 (br s, 1H), 3.45–3.29 (m, 8H),
2.63–2.54 (m, 4H), 2.44–2.29 (m, 2H), 2.34–2.27 (m, 2H); 2.11
(s, 3H), 2.06–2.05 (m, 3H), 2.02–1.98 (m, 12H), 1.93 (s, 3H),
1.67–1.52 (m, 4H); 13C NMR (100 MHz, CDCl3) (mixture of
rotamers) 174.9, 174.7, 172.8, 172.7, 170.6, 170.5, 170.3,
170.3, 170.1, 170.0, 169.8, 169.8, 169.7, 169.7, 169.6, 169.1,
169.1, 157.0, 156.7, 143.8, 143.7, 141.3, 141.2, 127.8, 127.7,
127.1, 125.0, 125.0, 120.0, 120.0, 101.0, 83.2, 76.1, 73.8, 70.9,
70.6, 70.3, 69.1, 66.9, 66.8, 66.6, 62.2, 62.1, 60.8, 60.8, 48.3,
47.9, 47.1, 46.00, 45.6, 39.9, 38.9, 38.4, 32.4, 32.2, 30.7, 29.7,
29.6, 29.5, 29.2, 29.1, 24.2, 20.8, 20.7, 20.7, 20.6, 20.4; HRMS
(ESI) m/z: [M + Na]+ calcd for C54H69N3O23SNa, 1182.3940;
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found, 1182.3956; RP-HPLC analysis, 5% to 95% MeCN in
10 min, retention time = 9.3 min.
H 2 N-β -GalS_DDS-AEEAc-  β -GalS_DDS-AEEAc-
β-GalS_DDS-AEEAc-CONH2 (14): Compound 14 (30 mg,
16.2 μmol) was obtained as white hygroscopic powder after
cleavage from the resin, precipitation into diethyl ether and
deactylation with a yield of 81%. MALDI–TOF–MS: [M +
Na]+ calcd for C75H135N13O33S3Na, 1864.83 (monoisotopic);
found, 1864.63; RP-HPLC analysis 5% to 95% MeCN in
10 min, retention time = 3.9 min.
AcHN-β-LacS_DDS-β-LacS_DDS-β-LacS_DDS-EDA (15):
Acetyl protected compound 15 was cleaved from the resin and
precipitated into diethyl ether. The crude material was purified
via preparative RP-HPLC (5 to 95% MeCN in 30 min) and
freezed-dried. After final deactylation compound 15 (11 mg,
5.6 μmol) was obtained as white hygroscopic powder with 28%
y i e l d .  M A L D I – T O F – M S :  [ M  +  H ] +  c a l c d  f o r
C79H140N11O40S3, 1978.84 (monoisotopic); found, 1979.06;
[M + Na]+ calcd for C79H139N11O40S3Na, 2000.82 (monoiso-
topic); found, 2000.88; [M + K]+ calcd for C79H139N11O40S3K,
2016.80 (monoisotopic); found, 2017.01; RP-HPLC analysis
5% to 50% MeCN in 30 min, retention time = 5.9 min.
AcHN-β-GlcNAcS_DDS-β-GalS_DDS-β-GlcNAcS_DDS-β-
GalS_DDS-β-GlcNAcS_DDS-β-GalS_DDS-β-EDA (16)
Acetyl protected compound 16 was cleaved from the resin and
precipitated into diethyl ether. After deactylation in solution, the
crude material was purified via preparative RP-HPLC (5 to 50%
MeCN in 30 min) and freezed-dried. Compound 16 (12.6 mg,
4.2 μmol) was obtained as white hygroscopic powder with 21%
y i e l d .  M A L D I – T O F – M S :  [ M  +  N a ] +  c a l c d  f o r
C124H217N23O49S6Na, 3027.34 (monoisotopic); found,
3027.71; RP-HPLC analysis 5% to 50% MeCN in 30 min,
retention time = 7.8 min.
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